New registry offers insights into quality of life for adults with congenital heart disease

For the first time, adults living with congenital heart disease (CHD) now have valuable insights into their long-term quality of life through data from the Congenital Heart Initiative (CHI).

FDA posts guidance on how to simplify updates to antimicrobial resistance tests

Dive Brief: The Food and Drug Administration has published final guidance on devices for determining the susceptibility of bacterial or fungal pathogens to different antimicrobial

September 29, 2023

Tessera unveils promising in vivo gene editing treatment for sickle cell in an increasingly competitive field: #ASGCT24

Tessera Therapeutics, a well-funded startup based outside of Boston, announced Friday that it developed a lipid nanoparticle that shuttles a gene editing therapy directly to

May 11, 2024

FDA rejects liver cancer drug combo, shares of Korean biotech tank

Korean biotech HLB and its China-based partner Jiangsu Hengrui Pharmaceuticals said Friday that the FDA rejected their drug combination for the most common form of

May 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.